Cincinnati Children's is conducting a research study, sometimes known as a clinical trial or clinical study, to learn about certain skin characteristics and how those characteristics are related to the severity of eczema and the skin’s response to different treatments. This research study is NIH funded and is part of the Atopic Dermatitis Research Network (ADRN).
Children 6 to 12 years old who have eczema and who either:
This study includes 10 visits to Cincinnati Children’s Hospital. Here are some of the things that will happen in this study:
Your child will have:
Participants/Caregivers will be given a consent form that thoroughly explains all of the details of the study. A member of the study staff will review the consent form with you and will be sure that all of your questions are answered.
Our ultimate goal through these studies will be to develop evidence-based, precision medicine approaches to address disease in the most severe eczema patients. Knowledge from this study may allow development to help eczema patients and dupilumab non-responders.
We will discuss possible risks or discomforts with those interested in learning more about the study.
Participants will be compensated for their time and effort.
Gurjit Khurana Hershey
Division of Asthma Research
Cincinnati Children’s Hospital Medical Center